Cargando…
Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial
BACKGROUND: It is challenging for outcome assessors to remain blinded during outcome assessment in trials with prospective randomized open blinded endpoint (PROBE) design. If assessors are able to guess the correct treatment allocation more often than expected based on chance, the assessors may have...
Autores principales: | van der Ende, Nadinda AM, Roozenbeek, Bob, Broderick, Joseph P, Khatri, Pooja, Lingsma, Hester F, Dippel, Diederik WJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196921/ https://www.ncbi.nlm.nih.gov/pubmed/36169032 http://dx.doi.org/10.1177/17474930221131706 |
Ejemplares similares
-
Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial
por: van der Ende, Nadinda A.M., et al.
Publicado: (2021) -
Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke
por: van der Ende, Nadinda A.M., et al.
Publicado: (2023) -
Prehospital Triage Strategies for the Transportation of Suspected Stroke Patients in the United States
por: Venema, Esmee, et al.
Publicado: (2020) -
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2020) -
Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome
por: van der Steen, Wouter, et al.
Publicado: (2023)